Countdown to IPBC Korea 2023
Just one month until IP leaders will gather in Seoul for an agenda tackling policy developments, market trends, and commercial pressures
Just one month until IP leaders will gather in Seoul for an agenda tackling policy developments, market trends, and commercial pressures
Opinion: Popular attacks on America’s life sciences patent system are highly misleading
Chief IP officers at large and small companies – especially life sciences – are closely watching the case which promises to settle debate about what comprises sufficient enablement under Section 112
IAM Q2 panel report reveals growing awareness of new European patent system’s strategic significance
26 September 2022
Saturday Opinion: Without a coherent approach to capturing domestic value from R&D including greater clarity on subject matter patentability, the positive consequences of higher US government funding will be felt as much in Berlin, Bangalore and Beijing as Boston
24 September 2022
Despite her caution against reading too much into her rulings, PTAB practitioners are noting patterns and predicting their significance
23 September 2022
With the retirement of Patrick Leahy and the overall race too close to call, uncertainty is the name of the game in Washington DC
14 September 2022
Patent bodies must adapt and evolve to address knowledge gaps in changing digital landscape
09 September 2022
Kathi Vidal says the agency is working with NIST and the Biden administration to build strategies that will lead to greater involvement
07 September 2022
The company’s October 2020 non-enforcement promise may be a roadblock for its legal action against Pfizer/BioNTech
03 September 2022
Former USPTO Director Andrei Iancu warns that the US is facing “a new Sputnik moment”, but he and others at an online event caution against reading too much into raw numbers
01 September 2022
Ninth Circuit Court of Appeal puts the breaks on whistleblower’s attempts to show deception in company’s dealings with the USPTO
01 September 2022
Although many provisions were stripped out of the final version of the legislation, it still contains important tech transfer-related elements, while the huge sums for R&D it envisages are almost certain to spawn more patents
30 August 2022
Unlock unlimited access to all IAM content